• Daria, being the General Director of GCT Polish office, what can you say about Poland’s involvement in clinical trials, and you experience in the country?

Our
office in Warsaw operates since 2017, and I have been working in clinical trials for more than 15
years. Polish sites started participating in multinational research studies one
of the first in Europe, on a par with Germany and other western European
countries. Polish investigators are involved in every aspect of the trial that
they take on. It has been great to see this industry maturing and institutions
developing relations with the rest of the industry leaders.

  • Can you talk more about your role and
    background?

I’m a doctor and my
specialty is neurosurgery. I have been working as a medical monitor and have
established a safety and PVG department, which actively works with EMA’s
Eudravigilance, and provides global safety support for the outside of EU GCT
countries.

Apart from this
activity, I’m managing a team of CRAs that is growing from year to year.  

  • Was the job what you expected it would
    be? Did anything surprise you?  

When I had joined GCT
I knew very well what could be expected in clinical trials work routine, but I
didn’t expect that our Polish branch could develop so quickly.  

  • What’s changed at the company since
    you’ve joined?  

We are now present in
an increasing number of countries. It means that we are a global CRO. As I
mentioned, in Poland in particular, we have developed pharmacovigilance
services that are extremely important, and we provide support to all
neighboring countries centrally now.

  • What is important for you in the
    corporate culture of GCT?

Professionalism,
flexibility, and a friendly atmosphere. Being a part of the GCT team gives me
the feeling that nothing is impossible.

  • Can you describe an event that was
    particularly memorable during your career at GCT?

Our
first international investigators’ meeting that was organized in Warsaw. It was
the first meeting in my career with GCT, and I wanted everything to be perfect.
The team did a wonderful job and Investigators were very engaged.

  • What was the moment when you knew you
    had made the right decision to work here?

Probably after my
first meeting with Eugene, GCT CEO. It is very important to know the people you
are working with. I was able to confirm this in practice after our first study
that included Poland was initiated. I know that this part of Europe has a big
experience and potential in clinical trials, and our latest projects prove it.

  • What do you think the mission of GCT
    is?

Further development.
Sometimes driven by the challenges that help us to grow, invent new
technologies and solutions.

  • Where do you see GCT in 10 years?

We
will continue to expand
by adding new countries, while still being innovative and flexible. Knowledge
of local requirements will remain our big advantage.